Oncología Traslacional
ONCTRAS
Luis Alfonso
Gurpide Ayarra
Consultor Médico
Publicaciones en las que colabora con Luis Alfonso Gurpide Ayarra (19)
2024
2021
-
Characterization of the perioperative changes of exosomal immune-related cytokines induced by prostatectomy in early-stage prostate cancer patients
Cytokine, Vol. 141
-
Whole exome sequencing characterization of individuals presenting extreme phenotypes of high and low risk of developing tobacco-induced lung adenocarcinoma
Translational Lung Cancer Research, Vol. 10, Núm. 3, pp. 1327-1337
2019
-
Identification of mutations associated with acquired resistance to sunitinib in renal cell cancer
International Journal of Cancer, Vol. 145, Núm. 7, pp. 1991-2001
2018
-
Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer
Cancer Medicine, Vol. 7, Núm. 7, pp. 3474-3483
2017
-
Strategies to design clinical studies to identify predictive biomarkers in cancer research
Cancer Treatment Reviews, Vol. 53, pp. 79-97
2016
-
Total and mutated EGFR quantification in cell-free DNA from non-small cell lung cancer patients detects tumor heterogeneity and presents prognostic value
Tumor Biology, Vol. 37, Núm. 10, pp. 13687-13694
2015
2013
-
Identificación de marcadores genómicos con valor pronóstico en pacientes diagnosticados de carcinoma de pulmón en estadio temprano mediante microarrays de single nucleotide polymorphisms (SNPs)
Anales del sistema sanitario de Navarra, Vol. 36, Núm. 1, pp. 167-169
2012
-
The multimodal management of locally advanced N2 non-small cell lung cancer: Is there a role for surgical resection? A single institution's experience
Clinical and Translational Oncology, Vol. 14, Núm. 11, pp. 835-841
2011
2010
2009
-
EUELC project: A multi-centre, multipurpose study to investigate early stage NSCLC, and to establish a biobank for ongoing collaboration
European Respiratory Journal, Vol. 34, Núm. 6, pp. 1477-1486
-
Role of surgery in a multidisciplinary approach to superior sulcus tumors (SST): Morbidity and prognostic factors for long-term success after resection
Thoracic and Cardiovascular Surgeon, Vol. 57, Núm. 6, pp. 353-357
2008
-
Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation
Radiotherapy and Oncology, Vol. 88, Núm. 3, pp. 342-350
2005
-
Activity of gefitinib in central nervous system metastases in patients with non-small-cell lung center: Two case reports and a review of the literature
Clinical Lung Cancer, Vol. 7, Núm. 2, pp. 138-140
2004
-
Paclitaxel, cisplatin, and vinorelbine combination chemotherapy in metastatic non-small-cell lung cancer
American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 27, Núm. 3, pp. 299-303
2003
-
Front-line paclitaxel/cisplatin-based chemotherapy in brain metastases from non-small-cell lung cancer
Oncology, Vol. 64, Núm. 1, pp. 28-35
1996
-
High-dose BCNU and autologous progenitor cell transplantation given with intra-arterial cisplatinum and simultaneous radiotherapy in the treatment of high-grade gliomas: Benefit for selected patients
Bone Marrow Transplantation, Vol. 18, Núm. 1, pp. 143-149